Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus

Search Close Search

Print

2020 RESEARCH

- Archives -

Shao-Hsien Liu studies racial disparities in total joint arthroplasty recovery

Shao-Hsien Liu studies racial disparities in total joint arthroplasty recovery

Racial disparities in utilization and outcomes of total joint arthroplasty, one of the most common surgical procedures performed in the United States, have persisted for 30 years, according to Shao-Hsien Liu, PhD.

From gut to brain: UMMS probes link between microbiome and cognitive functioning in Alzheimer’s patients

From gut to brain: UMMS probes link between microbiome and cognitive functioning in Alzheimer’s patients

UMass Medical School researchers have been awarded a $3.3 million, four-year National Institute on Aging grant to explore new understanding of how the gut microbiome influences cognitive functioning among elders living with Alzheimer’s disease.

More than half of COVID-19 clinical trials exclude older adults, according to research co-authored by MD/PhD student Benjamin Helfand

More than half of COVID-19 clinical trials exclude older adults, according to research co-authored by MD/PhD student Benjamin Helfand

A research letter published in JAMA Internal Medicine, co-authored by UMass Medical School MD/PhD student Benjamin Helfand, reports that older adults were likely to be excluded from more than 50 percent of COVID-19 clinical trials and 100 percent of vaccine trials initiated early in the pandemic.

Recent GSBS grad’s study published in Molecular Cell analyzes mapping of enhancer-promoter interactions for gene expression and role in pathogen detection

Recent GSBS grad’s study published in Molecular Cell analyzes mapping of enhancer-promoter interactions for gene expression and role in pathogen detection

Pranitha Vangala, PhD, GSBS ’20, is lead author of a study published in the journal Molecular Cell, in which she and colleagues present a predictive model of gene expression.

MassBiologics announces partnership with PTC Therapeutics to manufacture gene therapy for rare pediatric condition

MassBiologics announces partnership with PTC Therapeutics to manufacture gene therapy for rare pediatric condition

MassBiologics of UMass Medical School has entered into an agreement with PTC Therapeutics to manufacture biological investigational new drugs and commercial pharmaceutical products for use in humans.

UMMS researchers study attitudes toward potential COVID-19 vaccine

UMMS researchers study attitudes toward potential COVID-19 vaccine

As many as four in 10 adults would refuse or hesitate to get a COVID-19 vaccine, according to a national survey, results of which were published in the Annals of Internal Medicine. Study co-authors Kimberly Fisher, MD, and Kathleen Mazor, EdD, say the findings indicate that health education outreach would be necessary to achieve widespread uptake of a safe and effective vaccine.

Boston Globe, CNN: UMass Medical School seeking to enroll diverse communities in COVID vaccine trial

Boston Globe, CNN: UMass Medical School seeking to enroll diverse communities in COVID vaccine trial

Robert Finberg, MD, spoke with the Boston Globe and CNN about measures UMass Medical School has taken to reach a diverse population as it recruits for its involvement in the Pfizer/ BioNTech vaccine trail for COVID-19.

New awards from Massachusetts Life Sciences Center support women’s health research

New awards from Massachusetts Life Sciences Center support women’s health research

Medical device research projects by Gopal Vijayaraghavan, MD, MPH, and Mary Rusckowski, PhD, are among 11 projects that have received a total of $8.3 million in capital funding awards from the Massachusetts Life Sciences Center.

UMMS researcher co-directs project to enhance diversity in biomedical sciences workforce

UMMS researcher co-directs project to enhance diversity in biomedical sciences workforce

Mary Munson, PhD, is co-directing a first-of-its-kind national program to enhance diversity in the academic biomedical workforce, funded by a $1.3 million, five-year grant from the National Institutes of Health.

UMass Medical School announces participation and enrollment for vaccine trial candidate against COVID-19

UMass Medical School announces participation and enrollment for vaccine trial candidate against COVID-19

UMass Medical School is enrolling healthy volunteers to take part in a Phase II/III clinical trial testing whether a messenger RNA vaccine candidate can prevent infection with the virus that causes COVID-19.

Showing 1-10 of 81 items
of 9